Uncover Insights with BD-Tau and Key Neurology Biomarkers

Flyer

Whether your research is focused on a single neurology biomarker or spans the complex interactions of multiple markers, the Simoa® Neurology 4-Plex D (N4PD) Advantage PLUS assay delivers unmatched sensitivity, efficiency, and automated precision. With the capability to simultaneously measure NfL, GFAP, UCH-L1, and brain-derived Tau (BDTau) in both blood and cerebrospinal fluid (CSF), this assay streamlines your workflow and accelerates the discovery of critical insights for your next breakthrough.

These four biomarkers have significant established and emerging implications across the spectrum of neurodegenerative conditions, brain injury and more. Simoa® N4PD Advantage PLUS is an innovative tool that offers broad biomarker insights with added brain specificity from BD-Tau, all within the ease of a single assay workflow and single sample input. Download our flyer to learn more.

If you see this, do not fill:

Fill in the form below.

First Name *
Last Name *
Email *
Company *
What type of organization is your company? *
Country *
State *
Postal Code *
Therapeutic Area
To select multiple values, hold down the Shift or Control (PC) or Command (Mac) key.
What product(s) are you interested in? *
To select multiple values, hold down the Shift or Control (PC) or Command (Mac) key.
I consent

By submitting this form, you agree to Quanterix’s Terms of Use and Privacy Policy. In addition, you agree to receive information regarding Quanterix products and services. You will be able to unsubscribe at any time.